Dassault Systèmes is one of the world's two largest industrial software houses. It is the main independent alternative to Siemens' Digital Industries Software, and it has more than 390,000 customers in over 155 countries. Its business is the "virtual twin": a model of a product, a production system or a biological process, built on physics and science, that customers design, simulate, manufacture and manage on the 3DEXPERIENCE platform. Its brands include CATIA, SOLIDWORKS, ENOVIA, SIMULIA, DELMIA, BIOVIA, MEDIDATA and CENTRIC PLM. FY2025 revenue was €6.24bn, of which 82% of software revenue was recurring. The non-IFRS operating margin was 32.0%, and the balance sheet held net cash. Growth has slowed from about 9% in 2022 to 4% in 2025, mainly because the Medidata clinical-trials franchise has been weak and European automotive demand soft. Management's response is "3D UNIV+RSES": generative and agentic industrial AI built on science-validated "Industry World Models", backed by a strategic partnership with NVIDIA announced in February 2026. Life sciences was deepened further by the $1.8bn ArisGlobal acquisition, which closed in September 2026. In semiconductors, the company is building multi-scale twins that run from materials and plasma-process physics to wafer, equipment and cleanroom models.
**What the company does.** Dassault Systèmes develops and sells software, plus related cloud and services, that lets companies represent products, processes and living systems virtually across their whole lifecycle. That lifecycle runs from concept and 3D design through simulation, systems engineering, manufacturing planning and execution, product data management, collaboration and commercial experience. In life sciences, it also covers molecular discovery, clinical trials, regulatory submission and pharmacovigilance. The company describes itself as a "catalyst for human progress" that has created virtual worlds since 1981 to improve real life for consumers, patients and citizens (FY2025 Universal Registration Document, filed Mar 31, 2026).
**Business model.** Revenue comes overwhelmingly from software. In FY2025, software revenue was €5.64bn out of €6.24bn total, or about 90%, and services were €0.59bn, or about 10% (FY2025 earnings release, Feb 11, 2026). Software revenue has two streams:
**Licences and other software:** perpetual licences recognised up front. These were €1,020.7m in FY2025, down 6% in constant currency, as customers move to subscription.
**Subscription and support:** term subscriptions, cloud/SaaS and maintenance on the perpetual installed base. These were €4,624.1m in FY2025, up 6% in constant currency.
Recurring revenue was 82% of software revenue in FY2025, up from 80% in FY2024, and reached 83–85% in 2026 quarters. From 2026 the company reports Annual Run Rate (ARR), which was €4.50bn at Sep 30, 2026, up 6% in constant currency. Management expects subscription revenue to overtake maintenance revenue during 2026. Cloud software was 25% of software revenue in FY2025 and 28% in Q3 2026. 3DEXPERIENCE-based software was 41% of "3DEXPERIENCE-eligible" software revenue in FY2025 and 46% in Q3 2026.
**Value-chain position.** Dassault Systèmes sits at the top of the industrial value chain, in the intellectual-property creation layer that defines what gets built and how. Its software holds product definitions, bills of materials, simulation models, manufacturing process plans and, in life sciences, clinical and safety data. Switching costs are therefore very high. It sells directly to large enterprises through its Business Transformation and industry sales channels. It reaches small and mid-sized companies through a global value-added reseller network, used especially for SOLIDWORKS and 3DEXPERIENCE Works. Life Sciences sells directly to pharmaceutical companies, biotech firms and contract research organisations (CROs). The company also runs its own sovereign cloud infrastructure brand, OUTSCALE.
**Customer types and end markets.** The company groups its markets into three sectors. Shares of FY2025 non-IFRS software revenue are from the FY2025 URD:
**Manufacturing Industries:** Share of FY2025 software revenue (%): 71; Main industries: Transportation & Mobility (23% of software revenue), Industrial Equipment (17%), Aerospace & Defense (14%), High-Tech (including semiconductors and electronics), Home & Lifestyle, Consumer Packaged Goods & Retail, Business Services
**Life Sciences & Healthcare:** Share of FY2025 software revenue (%): 21; Main industries: Pharma, biotech, CROs, medical devices, hospitals and research institutions
**Infrastructure & Cities:** Share of FY2025 software revenue (%): 8; Main industries: Construction, cities & public services, energy & materials, marine & offshore, natural resources and mining
**Independent characterisation.** Dassault Systèmes is a high-margin, cash-generative vendor of mission-critical engineering software with two distinct engines:
1. **A mature, defensible core** in aerospace, automotive and industrial equipment. CATIA, ENOVIA, DELMIA and SIMULIA are de facto standards there, especially in Europe and among Airbus- and Boeing-linked supply chains. This core grows in the mid-single digits.
2. **Adjacent diversification bets:** life sciences (Medidata, BIOVIA, now ArisGlobal), consumer and fashion (Centric Software) and the mainstream SMB market (SOLIDWORKS). These have performed unevenly.
The investment debate centres on two questions. First, can the industrial-AI and virtual-twin agenda raise growth back toward high single digits? Second, has Life Sciences, now about 19–21% of software revenue, stabilised? In semiconductors, the company is a secondary but growing supplier. It offers 3DEXPERIENCE for semiconductor programme and IP management, SIMULIA electromagnetic and plasma simulation for equipment makers, DELMIA manufacturing operations software for fabs, and full fab virtual twins for yield, maintenance training and facility operations.